Related references
Note: Only part of the references are listed.The pharmacology of Adrenomedullin 2/Intermedin
Yanguo Hong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities
Jonathan D. Roth et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Neuronal Receptor Activity-Modifying Protein 1 Promotes Energy Expenditure in Mice
Zhongming Zhang et al.
DIABETES (2011)
Shared and separate functions of the RAMP-based adrenomedullin receptors
Kenji Kuwasako et al.
PEPTIDES (2011)
Interaction of Leptin and Amylin in the Long-term Maintenance of Weight Loss in Diet-induced Obese Rats
James L. Trevaskis et al.
OBESITY (2010)
Brainstem mechanisms of amylin-induced anorexia
Catarina Soares Potes et al.
PHYSIOLOGY & BEHAVIOR (2010)
Central amylin acts as an adiposity signal to control body weight and energy expenditure
Peter Y. Wielinga et al.
PHYSIOLOGY & BEHAVIOR (2010)
A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor
Joseph J. Gingell et al.
PEPTIDES (2010)
Insights into amylin-leptin synergy
James L. Trevaskis et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Control of food intake and energy expenditure by amylin-therapeutic implications
T. A. Lutz
INTERNATIONAL JOURNAL OF OBESITY (2009)
Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
Eric Ravussin et al.
OBESITY (2009)
Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-Coupling Efficiency of Amylin Receptors
Maria Morfis et al.
ENDOCRINOLOGY (2008)
Evidence that alpha-calcitonin gene-related peptide is a neurohormone that controls systemic lipid availability and utilization
Rachel N. Danaher et al.
ENDOCRINOLOGY (2008)
Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function
Tao Qi et al.
MOLECULAR PHARMACOLOGY (2008)
International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor
Debbie L. Hay et al.
PHARMACOLOGICAL REVIEWS (2008)
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
Jonathan D. Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
What makes a CGRP2 receptor?
D. L. Hay
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
The acute effect of amylin and salmon calcitonin on energy expenditure
Peter Y. Wielinga et al.
PHYSIOLOGY & BEHAVIOR (2007)
Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187
Bronislava R. Gedulin et al.
REGULATORY PEPTIDES (2006)
Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors -: The role of receptor activity modifying protein 1
Debbie L. Hay et al.
MOLECULAR PHARMACOLOGY (2006)
Pharmacology of the human CGRP1 receptor in Cos 7 cells
Richard J. Bailey et al.
PEPTIDES (2006)
Pramlintide in the treatment of type 1 and type 2 diabetes mellitus
GJ Ryan et al.
CLINICAL THERAPEUTICS (2005)
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes
DL Hay et al.
MOLECULAR PHARMACOLOGY (2005)
Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: A comparison with other calcitonin/intermedin family peptides in vertebrates
CL Chang et al.
PEPTIDES (2004)
Immunohistochemical mapping of calcitonin receptors in the adult rat brain
C Becskei et al.
BRAIN RESEARCH (2004)
Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins
K Kuwasako et al.
MOLECULAR PHARMACOLOGY (2004)
Novel fish-derived adrenomedullin in mammals: structure and possible function
Y Takei et al.
PEPTIDES (2004)
CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors:: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS
DL Hay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins
K Kuwasako et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins
K Kikumoto et al.
HYPERTENSION RESEARCH (2003)
International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors
DR Poyner et al.
PHARMACOLOGICAL REVIEWS (2002)
Inhibition of central amylin signaling increases food intake and body adiposity in rats
PA Rushing et al.
ENDOCRINOLOGY (2001)
Adrenomedullin receptors: molecular identity and function
DL Hay et al.
PEPTIDES (2001)
Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain
T Ueda et al.
MOLECULAR BRAIN RESEARCH (2001)
The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema nucleus of the solitary tract (AP/NTS) lesioned rats
TA Lutz et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition
K Leuthäuser et al.
BIOCHEMICAL JOURNAL (2000)
Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes
S Mäkimattila et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
